Skip to content
← Back to this collection

PUBLICATIONS · 29384722

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2018 Apr 10
First author
Kyriakopoulos CE

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2018 Apr 10;36(11):1060-1061. doi: 10.1200/JCO.2017.77.4315.
    note
    Source null
    related pmid
    29432079
    relationship
    Comment in

Authors and identifiers

  1. name
    Kyriakopoulos CE
    type
    Author
  2. name
    Chen YH
    type
    Author
  3. name
    Carducci MA
    type
    Author
  4. name
    Liu G
    type
    Author
  5. name
    Jarrard DF
    type
    Author
  6. name
    Hahn NM
    type
    Author
  7. name
    Shevrin DH
    type
    Author
  8. name
    Dreicer R
    type
    Author
  9. name
    Hussain M
    type
    Author
  10. name
    Eisenberger M
    type
    Author
  11. name
    Kohli M
    type
    Author
  12. name
    Plimack ER
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kyriakopoulos CE
    type
    Author
  2. name
    Chen YH
    type
    Author
  3. name
    Carducci MA
    type
    Author
  4. name
    Liu G
    type
    Author
  5. name
    Jarrard DF
    type
    Author
  6. name
    Hahn NM
    type
    Author
  7. name
    Shevrin DH
    type
    Author
  8. name
    Dreicer R
    type
    Author
  9. name
    Hussain M
    type
    Author
  10. name
    Eisenberger M
    type
    Author
  11. name
    Kohli M
    type
    Author
  12. name
    Plimack ER
    type
    Author
bibliography ids
  1. nci-bib-d7978e79489d24a5e5179c36
book metadata
content sha256
a0ab8f7ee10451c5e3016a2ed06b309e1c610f01aff1f97ccbc3a02fca444ef4
document type
citation
dois
  1. 10.1200/JCO.2017.75.3657
electronic publication date
display
2018 Jan 31
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29384722
immutable id
pubmed:29384722@a0ab8f7ee10451c5e3016a2ed06b309e1c610f01aff1f97ccbc3a02fca444ef4
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
11
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
1080-1087
volume
36
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2018 Apr 10;36(11):1060-1061. doi: 10.1200/JCO.2017.77.4315.
    note
    Source null
    related pmid
    29432079
    relationship
    Comment in
outcomes validated
false
pmid
29384722
provenance
batch id
ec9444d0f4cade22eb9f
provider
NCBI PubMed ESummary
record sha256
2ff0c470beb4e54e6f0b5571048783d5a43cf0a20d047ce393d9dae392d2174c
response sha256
6eef0d8cc09b77e73af656f6390cc734befb84fbc4c229b886e81e5d95bece31
retrieved at
2026-09-09T23:47:30.975610+00:00
publication date
display
2018 Apr 10
precision
day
year
2018
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, N.I.H., Extramural
  7. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29384722/
title
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial.

Preserved source evidence · Not medical advice